Severe intra-abdominal infection is associated with a high mortality r
ate. In addition to risk factors in the patients, the causal pathogens
and the selection of appropriate therapeutic procedures play an essen
tial part in the course of these conditions. In the majority of intra-
abdominal infections mixed aerobic/anaerobic infections, mostly with s
ome involvement of enterobacteria and also of enterococci and staphylo
cocci can be demonstrated. In addition to surgical intervention a calc
ulated antimicrobial initial treatment of intra-abdominal infections w
ith an antibiotic with an adequate effect to combat the pathogen conce
rned can contribute to improving the patient's prognosis. A calculated
antibiotic treatment can only be effectively and reliably carried thr
ough if the frequency of the pathogen and the restistance situation ar
e known. Retrospective evaluations of data on the sensitivity and freq
uency of pathogens from a defined group of subjects allow conclusions
on the epidemiological situation in a particular catchment area or in
a medical sector and thus make it possible to calculate the appropriat
e therapy for infections. In 1996 a total of 2,779 bacterial isolates
from the intra-abdominal infection sector were examined: 935 Enterobac
teriaceae, 83 nonfermenters, 177 Staphylococcus spp., 211 Enterococcus
spp., 39 Streptococcus spp., and 1334 different anaerobic bacteria. F
resh clinical isolates were available for all pathogens tested. The mo
st frequent gram-negative pathogen was E. coli (60%) and the most freq
uent gram-positive pathogen, E. faecalis (44%); the most frequent anae
robic pathogen was B. fragilis (39%). Taurolodine had the lowest resis
tance rate against gramnegative and anaerobic pathogens. Teicoplanin h
ad the highest activity against gram-positive pathogens.